NICE turns down BMS’ blockbuster Opdivo for urothelial carcinoma
July 5, 2018Sales and Marketing BMS, Bristol-Myers Squibb, NICE, opdivo, pharma, urothelial carcinoma
Just in time for the NHS’ 70th birthday, UK watchdog NICE has announced that it has taken the decision to …
Abivax drug lowers HIV DNA in blood and tissue, but has the opposite effect for some
July 4, 2018Research and Development Abivax, HIV, pharma
Biotechnology firm Abivax has lifted the curtain on new Phase 2a data for its HIV therapy ABX464, showing that the …
Review signals step towards legalisation of medicinal cannabis in UK
July 4, 2018Research and Development England, cannabis, pharma, review, thc
England’s Chief Medical Officer Dame Sally Davies has concluded that there is “conclusive evidence” that cannabis is medically beneficial for …
GSK Director indicted in Massachusetts opioid lawsuit
July 4, 2018Research and Development, Sales and Marketing
The state of Massachusetts has taken action to sue a board member at GlaxoSmithKline for her alleged role in fuelling …
The July/August issue of Pharmafocus is now live!
July 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Elizabeth Holmes, NHS, Sanofi, Theranos, UK, ambien, manufacturing compliance, opdivo, patient recruitment, patient retention, pharma
The new July/August edition of Pharmafocus is now available to read online.
Promising new drug slows Parkinson’s progression in mice
July 4, 2018Research and Development John Hopkins University, Parkinson's diabetes, pharma
Researchers from John Hopkins University have developed an experimental drug that slows the progression of Parkinson’s disease in mice. The …
Bayer expands Broad Institute partnership to focus on heart failure
July 3, 2018Manufacturing and Production, Research and Development Bayer, broad institute, collaboration, heart failure, pharma
The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology …
Lundbeck appoints new President and CEO
July 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ludbeck, pharma
The Danish pharmaceutical company Lundbeck has announced that the company’s Board of Directors have appointed Dr Deborah Dunshire as Lunbeck’s …
Cadila scores FDA approval for BMS and Alvogen generics
July 3, 2018Manufacturing and Production, Sales and Marketing Adolat, Alvogen, Bristol-Myers Squibb, Cadila, FDA, Questran, generics, pharma
Cadila Healthcare has announced that it has gained FDA final approval to market nifedipine ER tablets in the strengths of …
Novartis secures US rights to Adamis’ epinephrine auto injector
July 3, 2018Manufacturing and Production, Sales and Marketing Adamis, Novartis, Symjepi, US, auto injector, pharma
Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine auto injector Symjepi in the …
Unfazed by Trump, Pfizer hikes prices for 100 of its drugs
July 3, 2018Manufacturing and Production, Sales and Marketing Pfizer, President trump, Trump, pharma, price hikes
After a campaign full of not-so-veiled threats directed at the pharma industry, and a presidency which has so far failed …
Sanofi invests €66m in Chinese R&D hub
July 3, 2018Manufacturing and Production China, Sanofi, chengdu, development, pharma, research
French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and …
Global manufacturing harmonisation: Towards a worldwide safety network
July 2, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing compliance, feature, manufacturing, manufacturing compliance, pharma
Manufacturing of pharmaceuticals takes place all over the world and the health of patients globally is at stake. Ben Hargreaves …
EMA approves Cimzia for use in treating plaque psoriasis
July 2, 2018Sales and Marketing Cimzia, EMA, UCB, indication, pharmaceutical
The Brussels-based pharmaceutical company UCB has announced that the European Medicines Agency (EMA) has approved a label extension for Cimzia …
Roche’s Tecentriq combo gives strong Phase 3 showing in triple negative breast cancer
July 2, 2018Research and Development, Sales and Marketing Cancer, Roche, breast cancer, pharma
Roche has unveiled new Phase 3 data on its immunotherapy drug Tecentriq (atezolizumab) in combination with chemotherapy (Celgene’s Abraxane) as …
AstraZeneca chalks up double Japanese approval in lung and breast cancer
July 2, 2018Sales and Marketing AstraZeneca, Cancer, Imfinzi, NSCLD, breast cancer, lung cancer, lynparza, pharma
It’s a big step forward for AstraZeneca’s global marketing operations as the company announced that two of its products have …
Takeda’s Entyvio secures Japanese approval in ulcerative colitis
July 2, 2018Sales and Marketing Entyvio, Japan, Takeda, pharma, ulcerative colitis
Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio (vedolizumab), has been approved for the treatment of patients with moderately …
AbbVie ordered to pay $448m over generic delays
July 2, 2018Sales and Marketing AbbVie, FTC, androgel, besins, branded generics, pharma
A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham …
Top Ten most popular articles on Pharmafile.com this week
June 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Remicade, Roche, biosimilar Amgen, lung cancer, multiple sclerosis, pharma
Summer seems to be in full swing as we reach the end of June, so it’s time to look back …
Novartis spins off Alcon as CEO focuses drug search
June 29, 2018Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma
Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
